Abstract
Echocardiographically determined left ventricular (LV) hypertrophy is a powerful, independent predictor of cardiovascular morbidity and mortality. Both insulin resistance and obesity have a well-known association with LV hypertrophy. However, whether or not there are sex-related differences in the relations of insulin resistance and obesity to LV hypertrophy has never been systematically explored in Japan. We enrolled 91 never-treated hypertensive patients (49 men and 42 women) to assess the possible relations of insulin resistance and obesity to LV geometry. Insulin resistance was estimated using the homeostasis model assessment (HOMA) formula. Echocardiographically determined LV mass and relative wall thickness were measured as markers of LV geometry. In addition, body mass index (BMI) was calculated as weight (kg) divided by height (m)2 as a marker of obesity. Independent determinants of LV mass in male hypertensive patients were HOMA value (p<0.0001) and age (p=0.034). BMI did not bear a significant relation to LV mass. In comparison, in female hypertensive patients BMI was an independent determinant of LV mass (p=0.011). The HOMA value did not bear a significant relation to LV mass in the female hypertensive patients. In conclusion, these findings indicate the presence of sex-related differences in the relations of insulin resistance and obesity to LV hypertrophy in Japanese hypertensive patients. The effect of obesity on LV geometry was greater in female hypertensive patients than in male hypertensive patients.
Similar content being viewed by others
Article PDF
References
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli MP : Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH : Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.
Diamond JA, Phillips RA : Hypertensive heart disease. Hypertens Res 2005; 28: 191–202.
Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K : Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995; 13: 155–160.
Shigematsu Y, Hamada M, Okayama H, et al: Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997; 29: 723–727.
Shigematsu Y, Hamada M, Ohtsuka T, et al: Left ventricular geometry as an independent predictor for extracardiac target-organ damage in essential hypertension. Am J Hypertens 1998; 11: 1171–1177.
Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM : Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 1998; 97: 996–1001.
Fujiwara T, Saitoh S, Takagi S, et al: Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia. Hypertens Res 2005; 28: 665–670.
Rutter MK, Parise H, Benjamin EJ, et al: Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003; 107: 448–454.
Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Grossman E : Myocardial contractility and left ventricular function in obese patients with essential hypertension. Am J Cardiol 1988; 62: 594–597.
Kurata A, Shigematsu Y, Higaki J : Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res 2005; 28: 133–139.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus : Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute : The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC : Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412–419.
Sahn DJ, DeMaria A, Kisslo J, Weyman A, The Committee on M-Mode Standardization of the American Society of Echocardiography : Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.
Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
Teichholz LE, Kreulen T, Herman MV, Golin R : Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7–11.
Ferguson JJ, Julius S, Randall OS : Stroke volume–pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens 1984; 2 ( Suppl 3): 397–399.
Denker PS, Pollock VE : Fasting serum insulin levels in essential hypertension: a meta-analysis. Arch Intern Med 1992; 152: 1649–1651.
Lind L, Andersson PE, Andren B, Hanni A, Lithell HO : Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433–438.
Bonora E, Kiechl S, Willeit J, et al: Prevalence of insulin resistance in metabolic disorder: the Bruneck Study. Diabetes 1998; 47: 1643–1649.
Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S : Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90: 928–936.
Vetta F, Cicconetti P, Ronzoni S, et al: Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J 1998; 19: 326–331.
Verdecchia P, Reboldi G, Schillaci G, et al: Circulating insulin and insulin-like growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100: 1802–1807.
Strauss DS : Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 1984; 5: 356–367.
Hara-Nakamura N, Kohara K, Sumimoto T, Lin M, Hiwada K : Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens 1994; 7: 1110–1114.
Galvan AQ, Galetta F, Natali A, et al: Insulin resistance and hyperinsulinemia: no independent relation to left ventricular mass in humans. Circulation 2000; 102: 2233–2238.
Levy D, Anderson KM, Savage DD, Kannell WB, Christiansen JC, Castelli MP : Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988; 108: 7–13.
Hammond IW, Devereux RB, Alderman MH, Laragh JH : Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988; 12: 996–1004.
de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH : Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994; 23: 600–606.
de Simone G, Devereux RB, Roman MJ, et al: Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol 1991; 68: 1704–1708.
Gerstenblith G, Frederiksen J, Yin FC, Fortuin NJ, Lakatta EG, Weisfeldt ML : Echocardiographic assessment of a normal adult aging population. Circulation 1977; 56: 273–278.
Pearson AC, Gudipati CV, Labovitz AJ : Effects of aging on left ventricular structure and function. Am Heart J 1991; 121: 871–875.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shigematsu, Y., Norimatsu, S., Ohtsuka, T. et al. Sex-Related Differences in the Relations of Insulin Resistance and Obesity to Left Ventricular Hypertrophy in Japanese Hypertensive Patients. Hypertens Res 29, 499–504 (2006). https://doi.org/10.1291/hypres.29.499
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.29.499
Keywords
This article is cited by
-
2023 update and perspectives
Hypertension Research (2024)
-
Cross-sectional analysis of serum calcium levels for associations with left ventricular hypertrophy in normocalcemia individuals with type 2 diabetes
Cardiovascular Diabetology (2015)
-
Toll-Like Receptor 6 Ser249Pro Polymorphism Is Associated With Lower Left Ventricular Wall Thickness and Inflammatory Response in Hypertensive Women
American Journal of Hypertension (2010)
-
Sex-specific hemodynamic and non-hemodynamic determinants of aortic root size in hypertensive subjects with left ventricular hypertrophy
Hypertension Research (2009)
-
The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients
Hypertension Research (2009)
